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Background: The antiapoptotic and epithelial–mesenchymal transition activities of Twist have been implicated
in the neoplastic transformation and the development of metastasis, respectively. Upregulation of Twist,
described in several types of human cancer, also acts as a prognostic marker of poor outcome.
Aim: To investigate Twist expression in oesophageal squamous cell carcinoma (SCC) and its prognostic value
in a Chinese cohort of patients with oesophageal SCC.
Methods: Twist expression in primary oesophageal SCC of 87 Chinese patients was investigated by
immunohistochemical staining. Twist protein level in one immortalised normal oesophageal epithelial cell line
and six oesophageal SCC cell lines was measured by western blot analysis. Twist mRNA level in 30 pairs of
frozen specimens of primary oesophageal SCC and non-neoplastic oesophageal epithelium from the upper
resection margin of corresponding oesophagectomy specimen was also determined by semiquantitative
reverse transcription-PCR.
Results: It was found that Twist was upregulated in oesophageal SCC cell lines, and its mRNA and protein
levels were both increased in oesophageal SCC and the non-neoplastic oesophageal epithelium (p,0.001).
In addition, a high level of Twist expression in oesophageal SCC was significantly associated with a greater
risk for the patient of developing distant metastasis within 1 year of oesophagectomy (OR 3.462, 95% CI
1.201 to 9.978; p = 0.022).
Conclusions: Our results suggest that upregulation of Twist plays a role in the neoplastic transformation to
oesophageal SCC and subsequent development of distant metastasis. Twist may serve as a useful prognostic
marker for predicting the development of distant metastasis in oesophageal SCC.
T
wist, a basic helix—loop–helix transcription factor, has
been recently identified as a promoting factor for
epithelial–mesenchymal transition (EMT),1 which
enhances the metastatic potential of cancer cells.2 Epithelial
cells lose their polarity and express genes specific for
mesenchymal cells during EMT. Mobility of the cells is thus
increased. Snail, which has also been described to promote
EMT, works similar to Twist in gastrulation and neural crest
development.3 It also acts as an inducer of cell movement and
survival to promote cancer progression.4 Similar to Snail, Twist
works as an EMT promoter, which downregulates E-cadherin
to increase cell mobility1 5 and also acts as an anti-apoptotic
factor to enhance the survival of a cancer cell.5
Snail has been shown to be overexpressed in 83% of cases
with oesophageal squamous cell carcinoma (SCC).6
Upregulation of Slug, a member of the Snail repressor family
and a suppressor of E-cadherin expression,7 has been demon-
strated to relate to poor clinical outcomes in oesophageal SCC.8
To our knowledge, there has not been any report on the
prognostic significance of Twist in oesophageal SCC, the eighth
most common cancers and the sixth most frequent cause of
cancer-related death worldwide.9 We set out to study Twist
expression in archival clinical samples of oesophageal SCC by
immunohistochemical methods and to correlate its expression
level with the clinicopathological data of the patient cohort. Our
study showed that Twist is generally upregulated in oesopha-
geal SCC. In addition, a high-level expression of Twist in the
primary tumour correlated significantly with the risk of
subsequent development of distant metastasis.
MATERIALS AND METHODS
Patients and specimens
The cohort comprised 87 Chinese patients with oesophageal
SCC who had undergone total oesophagectomy in Queen Mary
Hospital, Hong Kong, China, from 1998 to 2005. Excluded from
the study were patients who had received treatment directed
against oesophageal SCC before surgical resection of the
primary tumour. All clinical data were prospectively collected.
The archival formalin-fixed and paraffin wax-embedded tissue
blocks of the oesophagectomy specimens were retrieved from
the Department of Pathology, Queen Mary Hospital. The age of
patients at the time of procurement of the tissue samples
ranged from 22 to 87 (median 67) years. Median follow-up was
13 months (range 1 to 65 months). Cancer stage at the time of
oesophagectomy was classified according to the tumour–node–
metastasis staging system. The primary tumours were divided
into three grades: well, moderately and poorly differentiated
according to the World Health Organization classification.10
Table 1 lists the clinicopathological data of the patients. In 30 of
87 oesophagectomy specimens, fresh frozen tissues of the
primary tumour and the non-neoplastic upper resection margin
were available for molecular analysis.
A group of 64 patients was selected for statistical analysis on
Twist expression and development of metastasis within 1 year
of oesophagectomy. In total, 23 patients were excluded from
this analysis for two reasons. First, the patient was alive, with
Abbreviations: EMT, epithelial–mesenchymal transition; FBS, fetal bovine
serum; RT-PCR, reverse transcription-PCR; SCC, squamous cell carcinoma
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no known distant metastasis, but length of clinical follow-up
was ,1 year. Second, the patient was dead within 1 year of
oesophagectomy, and the metastatic potential of the primary
oesophageal SCC could not be interpreted. The selected group of
patients (n = 64) was further divided into two groups: the
metastatic (metastatic lesion was detected at the time or within
1 year of oesophagectomy) and non-metastatic groups (no
metastatic lesion was detected until the end of this study with a
minimum follow-up of 1 year).
Cell l ines
NE3 was maintained in keratinocyte serum-free medium
(Invitrogen). The cell lines EC1, EC18, and KYSE520 were
maintained in RPMI 1640 (Invitrogen) with 10% fetal bovine
serum (FBS). HKESC2 was maintained in 80% modified Eagle’s
medium with 20% FBS. KYSE150 and KYSE450 were main-
tained in 1:1 RPMI 1640/ (Invitrogen, Carlsbad, California,
USA) Ham’s F12 medium with 2% and 10% FBS, respectively.
Reverse transcription PCR
From the 87 patients included in this study, 30 paired tumour/
non-neoplastic frozen tissue samples were available for total
RNA extraction. The presence or absence of tumour cells in
these specimens was verified by histological assessment by a
pathologist (K-WC).
Total RNA was isolated from frozen sections using Trizol
reagent according to the manufacturer’s instructions
(Invitrogen). First-strand complementary DNA was synthesised
using 2 mg of total RNA by the SuperScript First Strand
Synthesis System (Invitrogen). Twist reverse transcription
(RT)-PCR was performed using TwRTF (59-CGG ACA AGC
TGA GCA AGA TT-39) and TwRTR (59-CCT TCT CTG GAA ACA
ATG AC-39) with cycling as follows: 10 min at 95 C˚ followed by
36 cycles of 30 s at 95 C˚, 30 s at 55 C˚ and 30 s at 72 C˚, with the
final 7 min extension at 72 C˚. b-Actin was used as an internal
control. The PCR products were verified by 1% agarose gel
electrophoresis. The intensity of the RT-PCR product was
analysed by Gelworks 1D Intermediate software V.3.01
(UVP). The intensity ratio of Twist RT-PCR product to b-actin
RT-PCR product was calculated. A ratio of 0–0.2 was regarded
as negative (0), 0.2–0.5 as weakly positive (1) and .0.5 as
positive (2), for statistical analysis.
Western blotting
Western blot was performed using primary antibodies against
Twist (1:250, Santa Cruz Biotechnology, Santa Cruz, California,
USA) as described previously.11 Actin (Santa Cruz
Biotechnology) was used as a loading control.
Immunohistochemical staining
Immunohistochemical staining using Dako EnVision+ system-
horse radish peroxidase (Dako Corporation, Carpinteria,
California, USA) was carried out according to the manufac-
turer’s instructions. Polyclonal anti-Twist (H-81) antibody
(Santa Cruz Biotechnology) was applied at a 1:500 dilution
for overnight incubation at 4 C˚.
Evaluation of immunohistochemical staining results
The stained sections were reviewed by two independent
observers (K-WC and Y-PC) who had no knowledge of the
patient data. Staining intensity was graded as follows: negative
(0), weak (1), moderate (2) and strong (3). Staining extent was
rated according to the percentage of positive cells. Samples with
no stained tumour cells were rated as 0 and those with ,25% of
stained tumour cells were rated as 1, those with 25–50% of
stained tumour cells were rated as 2 and those with .50% of
stained tumour cells were rated as 3. The results of staining
intensity and extent gave an overall staining score. An overall
score of 0 was marked as negative, 1–2 as weak, 3–4 as
moderate and 5–6 as strong. Negative or weak overall staining
was regarded as low Twist expression, whereas moderate or
Table 1 Clinical and pathological features of
patients
Cases, n (%)
Total 87
Sex
Male 67 (77)
Female 20 (63)
T stage
T1 2 (2)
T2 14 (16)
T3 53 (61)
T4 18 (21)
N stage
N0 32 (37)
N1 55 (63)
M stage
M0 72 (83)
M1 15 (17)
Histological grade
Well differentiated 13 (15)
Moderately differentiated 50 (58)
Poorly differentiated 23 (27)
Metastatic status, total 64
Non-metastatic 36 (56)
Metastatic (within 1 year) 28 (44)
Median (range) age of patients is 67 (22–87) years.
TWIST
b  Actin
N
E3
EC
1
EC
18
H
KE
SC
2
KY
SE
30
KY
SE
45
0
KY
SE
52
0
Figure 1 TWIST expression in immortalised normal oesophageal cell line
and oesophageal squamous cell carcinoma (SCC) cell lines. Upper panel
shows western blot analysis of TWIST expression in immortalised
oesophageal cell line (NE3) and six oesophageal SCC cell lines. TWIST
expression in NE3 is lower than in the six oesophageal SCC cell lines.
Lower panel shows western blot analysis of b-actin as control.
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Figure 2 Reverse transcription PCR (RT-PCR) of TWIST in human
oesophageal specimens. Upper panel shows representative TWIST RT-PCR
results in paired non-neoplastic oesophageal epithelium (NT)/oesophageal
squamous cell carcinoma (T) specimens. Non-neoplastic specimens were
the upper resection margin of oesophagectomy specimens. The absence of
tumour cells was confirmed by a pathologist by examining H&E-stained
specimens. Lower panel shows b-actin RT-PCR results for normalisation.
TWIST is upregulated in oesophageal tumour specimens compared with
paired non-neoplastic samples. The intensity ratio of the TWIST RT-PCR
product to b-actin RT-PCR product for each specimen is displayed in
parenthesis. A ratio of ,0.2 was regarded as negative, between 0.2 and
0.5 as weakly positive and .0.5 as positive.
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strong overall staining was regarded as high Twist expression in
the binary logistic regression analysis.
Statistical analysis
Statistical analysis was performed using SPSS V.11.5 software.
Differences in Twist expression among different clinicopatho-
logical stages were analysed by x2 test or Fisher’s exact test
where applicable. The association between Twist expression
and the risk of developing metastatic disease was estimated by
odds ratio (OR) and 95% CI using binary logistic regression
analysis. Spearman’s rank correlation test was applied to
analyse the correlation between Twist mRNA level measured
by RT-PCR and Twist protein score as assessed by immunohis-
tochemistry. A p value ,0.05 was considered to be significant.
RESULTS
Upregulation of Twist in oesophageal SCC cell lines
We examined Twist expression by RT-PCR and western blot
analysis in a normal immortalised cell line, NE3, and in six
oesophageal SCC cell lines. As shown in fig 1, all six
oesophageal SCC cell lines expressed higher levels of Twist
than did NE3. This result suggests that Twist is upregulated in
oesophageal SCC cells.
Upregulation of Twist in oesophageal SCC specimens
We compared Twist mRNA expression level in 30 frozen tumour
specimens with their paired non-neoplastic oesophageal
epithelium at the upper resection margin by semiquantitative
RT-PCR. As shown in fig 2 and table 2A, Twist mRNA was
detected in 67% (20 of 30) tumour specimens, whereas only
20% (6 of 25) of their non-neoplastic oesophageal epithelium
expressed Twist mRNA to the level that is detectable by RT-PCR
(p,0.001).
Twist protein level in 87 paraffin wax-embedded tumours
and 33 case-matched non-neoplastic oesophageal epithelium
embedded in paraffin wax-embedded (non-neoplastic oeso-
phageal epithelium at the upper resection margin) were
compared by immunohistochemistry. As shown in figs 3 and
4A and in table 2, 36% (31 of 87) oesophageal SCC specimens
showed moderate to strong Twist staining whereas only 3% (1
of 33) non-neoplastic oesophageal epithelium showed similar
staining extent. Twist protein level was significantly increased
in oesophageal SCC specimens compared with non-neoplastic
oesophageal epithelium (p,0.001). The staining patterns
observed were different between oesophageal SCC and
non-neoplastic oesophageal epithelium. In the Twist-positive
oesophageal SCC, Twist staining gave a diffuse cytoplasmic
pattern whereas in Twist-positive non-neoplastic oesophageal
epithelium, Twist staining was mainly localised to the peri-
nuclear area.
Spearman’s rank test was applied to correlate between Twist
mRNA level and Twist protein level. The result showed that
Twist mRNA expression level is correlated with Twist protein
expression level in our patient cohort (r 0.643, p,0.001).
In our patient cohort (n = 87), a high level of Twist
expression did not correlate with tumour–node–metastasis
staging, histological grading of tumour or patient survival.
High level of Twist expression in primary oesophageal
SCC tumour is associated with greater risk of distant
metastasis development
It has been suggested that upregulation of Twist in cancer cells
promotes EMT and metastasis.2 To investigate whether a high
level of Twist expression in primary oesophageal SCC could be a
predictor of development of distant metastasis, we studied
Twist protein levels in primary oesophageal SCC in our cohort
and examined their relationship with the occurrence of distant
metastasis within 1 year.
As shown in fig 4B and table 2C, 54% (15 of 28) patients with
moderate or strong Twist staining scores developed distant
metastasis within 1 year whereas only 25% (9 of 36) patients
with negative or weak Twist staining scores developed distant
metastasis within 1 year. Oesophageal SCC primary tumours
with higher Twist expression showed a trend to develop distant
metastasis more frequently, although the difference was not
significant (p = 0.054) when tumours were stratified into four
groups by their Twist expression level. However, when the
oesophageal SCC primary tumours were divided into two
groups with low (negative or weak) and high (moderate or
strong) Twist expression for binary regression analysis, high
level of Twist expression in the primary oesophageal SCC was
significantly associated with a higher risk for the patient to
develop distant metastasis (OR = 3.462, 95% CI 1.201 to 9.978;
p = 0.022).
DISCUSSION
By comparing TWIST expression in human oesophageal SCC
specimens with non-neoplastic oesophageal epithelium, we
found that Twist is upregulated in oesophageal SCC (p,0.001).
Upregulation of Twist and its prognostic value have been
Table 2 Summary of TWIST expression results*
(A) TWIST mRNA expression samples, n (%) Total, n
Negative Weakly positive Positive
Non-neoplastic 24 (80) 3 (10) 3 (10) 30
Tumour 10 (33) 11 (37) 9 (30) 30
(B)
TWIST protein expression samples, n (%) Total, n
Negative Weak Moderate Strong
Non-neoplastic 19 (58) 13 (39) 1 (3) 0 (0) 33
Tumour 17 (19) 39 (45) 25 (29) 6 (7) 87
(C) TWIST protein expression sample, n (%) Total, n
Negative Weak Moderate Strong
Non-metastatic 6 (17) 21 (58) 7 (19) 2 (6) 36
Metastatic 6 (21) 7 (25) 12 (43) 3 (11) 28
*(A) TWIST mRNA level, (B) TWIST protein level in non-neoplastic squamous epithelium and tumour specimens, (C)
TWIST protein level in oesophageal squamous cell carcinoma of non-metastatic group and metastatic group.
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described in several human cancers. In human breast cancer,
increased Twist expression has been shown to correlate with
metastasis development and shorter survival.12 Increased Twist
expression has also been suggested to associate with poor
outcome and shorter patient survival in patients with mela-
noma.13 In addition, Twist expression has recently been found
to correlate with lymph node metastasis, distant metastasis and
survival in nasopharyngeal carcinoma.14 This background
information prompted us to investigate whether Twist expres-
sion in oesophageal SCC could be of any prognostic signifi-
cance. This study showed that a high level of Twist expression
in the primary oesophageal SCC was associated with an
increased risk for the patient to develop distant metastasis.
These results suggest that Twist could be used as a prognostic
marker in predicting development of distant metastasis in
patients with oesophageal SCC.
We demonstrated that Twist expression in the six human
oesophageal SCC cell lines were higher than in the normal
immortalised oesophageal cell line (fig 1) and that both Twist
mRNA and protein levels in oesophageal SCC specimens were
increased compared with non-neoplastic oesophageal epithe-
lium (figs 2 and 3). Furthermore, upto 81% of oesophageal SCC
specimens showed positive Twist staining. These results suggest
that upregulation of Twist could be involved in the neoplastic
transformation of oesophageal epithelium. Twist is known to be
antiapoptotic in other cancers.15 It is likely that upregulation of
Twist plays a role in the neoplastic transformation of
oesophageal epithelium through its antiapoptotic activity.
Upregulation of Twist in breast cancer cells1 and prostate
cancer cells11 increased their invasiveness in vitro. By means of
binary logistic regression analysis, we found that a high level of
Twist expression in our cohort conferred a significantly higher
risk of developing distant metastasis. The results lend support
to the hypothesis that upregulation of Twist in oesophageal
SCC cancer cells might enhance metastasis through EMT. As
other two EMT promoters, Snail6 and Slug,8 have been shown to
be upregulated in oesophageal SCC, it is worth investigating
how Twist, Snail and Slug interact to promote metastasis in
oesophageal SCC.
We observed that the pattern of Twist staining in oesopha-
geal SCC specimens was different from that of the non-
neoplastic oesophageal epithelium. Although the staining was
cytoplasmic in both, it was diffusely cytoplasmic in the Twist-
positive oesophageal SCC cells, whereas it was typically
perinuclear in the non-neoplastic oesophageal epithelium
(fig 3). Subcellular localisation of Twist, in addition to its
expression level, has been implicated in cell fate decisions.16
Further studies are required to validate our observations and to
A
B
C
D
E
F
Non  neoplastic
 oesophageal
epithelium
Low TWIST
expression
High TWIST
expression
Oesophageal squamous
cell carcinoma
Figure 3 Immunohistochemical staining of TWIST in human oesophageal specimens. (A,B) Representative TWIST staining in non-neoplastic oesophageal
epithelium. (A) Non-neoplastic squamous cells show negative staining of TWIST and (B) TWIST-positive non-neoplastic cells show weak perinuclear staining.
(C–F) Representative TWIST staining in oesophageal squamous cell carcinoma (SCC) tumour specimens. (C) Negative, (D) weak, (E) moderate and (F) strong
TWIST staining were observed in our cohort of patients with oesophageal SCC. As many as 36% oesophageal SCC specimens express either moderate or
strong level of TWIST, but only 3% of their non-neoplastic counterparts express TWIST in the similar level.
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understand the mechanisms involved and the significance of
this differential subcellular localisation of Twist expression as
cells go through the process of neoplastic transformation to
oesophageal SCC.
In conclusion, our study demonstrated that upregulation of
Twist may play a role in the neoplastic transformation of
oesophageal epithelium and that a high level expression of
Twist in the primary tumour may further promote the
development of metastasis. Our results showed that Twist
might be a useful prognostic marker for predicting the
development of distant metastasis in oesophageal SCC.
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Figure 4 Summary of immunohistochemical staining of TWIST in primary
oesophageal squamous cell carcinoma (SCC) specimens. (A) TWIST
expression level in non-neoplastic oesophageal epithelium and
oesophageal SCC tumour specimens. (B) TWIST expression level in primary
oesophageal SCC of non-metastatic and metastatic groups.
Take-home messages
N TWIST is significantly upregulated in oesophageal
squamous cell carcinoma (SCC)
N A high level of TWIST in the primary oesophageal SCC
tumours was significantly associated with a higher risk of
distant metastasis development in the corresponding
patients
N These findings suggest that TWIST might be involved in
neoplastic transformation of oesophageal SCC through
its antiapoptotic activity, and it might participate in the
development of distant metastasis through its ability to
promote epithelium–mesenchymal transition.
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